SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-038053
Filing Date
2024-08-21
Accepted
2024-08-21 17:41:09
Documents
4
Period of Report
2024-08-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1724276463.html 4  
1 FORM 4 wk-form4_1724276463.xml 4 3146
2 EX-24 exhibit24selsavagepoa.htm EX-24 4394
3 exhibit24selsavagepoa001.jpg GRAPHIC 247294
4 exhibit24selsavagepoa002.jpg GRAPHIC 34724
  Complete submission text file 0001628280-24-038053.txt   397818
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Issuer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 490 HILL STREET APT 5 SAN FRANCISCO CA 94114
Business Address
Selsavage Joseph Anthony (Reporting) CIK: 0001943360 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39587 | Film No.: 241229588